A detailed history of Xtx Topco LTD transactions in Genmab A/S stock. As of the latest transaction made, Xtx Topco LTD holds 25,429 shares of GMAB stock, worth $523,583. This represents 0.05% of its overall portfolio holdings.

Number of Shares
25,429
Previous 11,751 116.4%
Holding current value
$523,583
Previous $295,000 109.83%
% of portfolio
0.05%
Previous 0.03%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$23.84 - $28.48 $326,083 - $389,549
13,678 Added 116.4%
25,429 $619,000
Q2 2024

Aug 12, 2024

SELL
$25.13 - $30.27 $269,016 - $324,040
-10,705 Reduced 47.67%
11,751 $295,000
Q1 2024

May 13, 2024

BUY
$26.43 - $32.77 $257,692 - $319,507
9,750 Added 76.74%
22,456 $671,000
Q4 2023

Feb 13, 2024

BUY
$27.94 - $35.44 $355,005 - $450,300
12,706 New
12,706 $404,000
Q4 2022

Feb 14, 2023

BUY
$33.8 - $47.06 $369,129 - $513,942
10,921 New
10,921 $462,000
Q3 2021

Nov 12, 2021

SELL
$41.55 - $48.72 $211,447 - $247,936
-5,089 Closed
0 $0
Q2 2021

Aug 12, 2021

BUY
$32.88 - $44.57 $167,326 - $226,816
5,089 New
5,089 $208,000

Others Institutions Holding GMAB

About GENMAB A/S


  • Ticker GMAB
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 658,292,992
  • Market Cap $13.6B
  • Description
  • Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...
More about GMAB
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.